Global Bronchodilator Market Insights and Forecast to 2028

Publisher Name :
Date: 26-Jan-2022
No. of pages: 110
Inquire Before Buying

Bronchodilator market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Bronchodilator market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Short-acting Bronchodilator

- Long-acting Bronchodilator

Segment by Application

- Asthma

- Chronic Obstructive Pulmonary Disease

- Others

By Company

- GlaxoSmithKline

- Roche

- AstraZeneca

- Boehringer Ingelheim

- Amgen

- Kissei Pharmaceutical

- Mitsubishi Tanabe Pharma

- Sanofi

- Theron Pharmaceuticals

- Array BioPharma

- Kyowa Hakko Kirin

- Verona Pharma

- Nycomed Pharma

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Bronchodilator Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Bronchodilator Product Introduction
1.2 Market by Type
1.2.1 Global Bronchodilator Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Short-acting Bronchodilator
1.2.3 Long-acting Bronchodilator
1.3 Market by Application
1.3.1 Global Bronchodilator Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Asthma
1.3.3 Chronic Obstructive Pulmonary Disease
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bronchodilator Sales Estimates and Forecasts 2017-2028
2.2 Global Bronchodilator Revenue Estimates and Forecasts 2017-2028
2.3 Global Bronchodilator Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Bronchodilator Sales by Region
2.4.1 Global Bronchodilator Sales by Region (2017-2022)
2.4.2 Global Sales Bronchodilator by Region (2023-2028)
2.5 Global Bronchodilator Revenue by Region
2.5.1 Global Bronchodilator Revenue by Region (2017-2022)
2.5.2 Global Bronchodilator Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Bronchodilator Sales by Manufacturers
3.1.1 Global Top Bronchodilator Manufacturers by Sales (2017-2022)
3.1.2 Global Bronchodilator Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bronchodilator in 2021
3.2 Global Bronchodilator Revenue by Manufacturers
3.2.1 Global Bronchodilator Revenue by Manufacturers (2017-2022)
3.2.2 Global Bronchodilator Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Bronchodilator Revenue in 2021
3.3 Global Bronchodilator Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bronchodilator Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bronchodilator Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bronchodilator Sales by Type
4.1.1 Global Bronchodilator Historical Sales by Type (2017-2022)
4.1.2 Global Bronchodilator Forecasted Sales by Type (2023-2028)
4.1.3 Global Bronchodilator Sales Market Share by Type (2017-2028)
4.2 Global Bronchodilator Revenue by Type
4.2.1 Global Bronchodilator Historical Revenue by Type (2017-2022)
4.2.2 Global Bronchodilator Forecasted Revenue by Type (2023-2028)
4.2.3 Global Bronchodilator Revenue Market Share by Type (2017-2028)
4.3 Global Bronchodilator Price by Type
4.3.1 Global Bronchodilator Price by Type (2017-2022)
4.3.2 Global Bronchodilator Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Bronchodilator Sales by Application
5.1.1 Global Bronchodilator Historical Sales by Application (2017-2022)
5.1.2 Global Bronchodilator Forecasted Sales by Application (2023-2028)
5.1.3 Global Bronchodilator Sales Market Share by Application (2017-2028)
5.2 Global Bronchodilator Revenue by Application
5.2.1 Global Bronchodilator Historical Revenue by Application (2017-2022)
5.2.2 Global Bronchodilator Forecasted Revenue by Application (2023-2028)
5.2.3 Global Bronchodilator Revenue Market Share by Application (2017-2028)
5.3 Global Bronchodilator Price by Application
5.3.1 Global Bronchodilator Price by Application (2017-2022)
5.3.2 Global Bronchodilator Price Forecast by Application (2023-2028)
6 North America
6.1 North America Bronchodilator Market Size by Type
6.1.1 North America Bronchodilator Sales by Type (2017-2028)
6.1.2 North America Bronchodilator Revenue by Type (2017-2028)
6.2 North America Bronchodilator Market Size by Application
6.2.1 North America Bronchodilator Sales by Application (2017-2028)
6.2.2 North America Bronchodilator Revenue by Application (2017-2028)
6.3 North America Bronchodilator Market Size by Country
6.3.1 North America Bronchodilator Sales by Country (2017-2028)
6.3.2 North America Bronchodilator Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Bronchodilator Market Size by Type
7.1.1 Europe Bronchodilator Sales by Type (2017-2028)
7.1.2 Europe Bronchodilator Revenue by Type (2017-2028)
7.2 Europe Bronchodilator Market Size by Application
7.2.1 Europe Bronchodilator Sales by Application (2017-2028)
7.2.2 Europe Bronchodilator Revenue by Application (2017-2028)
7.3 Europe Bronchodilator Market Size by Country
7.3.1 Europe Bronchodilator Sales by Country (2017-2028)
7.3.2 Europe Bronchodilator Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Bronchodilator Market Size by Type
8.1.1 Asia Pacific Bronchodilator Sales by Type (2017-2028)
8.1.2 Asia Pacific Bronchodilator Revenue by Type (2017-2028)
8.2 Asia Pacific Bronchodilator Market Size by Application
8.2.1 Asia Pacific Bronchodilator Sales by Application (2017-2028)
8.2.2 Asia Pacific Bronchodilator Revenue by Application (2017-2028)
8.3 Asia Pacific Bronchodilator Market Size by Region
8.3.1 Asia Pacific Bronchodilator Sales by Region (2017-2028)
8.3.2 Asia Pacific Bronchodilator Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Bronchodilator Market Size by Type
9.1.1 Latin America Bronchodilator Sales by Type (2017-2028)
9.1.2 Latin America Bronchodilator Revenue by Type (2017-2028)
9.2 Latin America Bronchodilator Market Size by Application
9.2.1 Latin America Bronchodilator Sales by Application (2017-2028)
9.2.2 Latin America Bronchodilator Revenue by Application (2017-2028)
9.3 Latin America Bronchodilator Market Size by Country
9.3.1 Latin America Bronchodilator Sales by Country (2017-2028)
9.3.2 Latin America Bronchodilator Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Bronchodilator Market Size by Type
10.1.1 Middle East and Africa Bronchodilator Sales by Type (2017-2028)
10.1.2 Middle East and Africa Bronchodilator Revenue by Type (2017-2028)
10.2 Middle East and Africa Bronchodilator Market Size by Application
10.2.1 Middle East and Africa Bronchodilator Sales by Application (2017-2028)
10.2.2 Middle East and Africa Bronchodilator Revenue by Application (2017-2028)
10.3 Middle East and Africa Bronchodilator Market Size by Country
10.3.1 Middle East and Africa Bronchodilator Sales by Country (2017-2028)
10.3.2 Middle East and Africa Bronchodilator Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Bronchodilator Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Overview
11.2.3 Roche Bronchodilator Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Roche Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Roche Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Corporation Information
11.3.2 AstraZeneca Overview
11.3.3 AstraZeneca Bronchodilator Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 AstraZeneca Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AstraZeneca Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Overview
11.4.3 Boehringer Ingelheim Bronchodilator Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Boehringer Ingelheim Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Boehringer Ingelheim Recent Developments
11.5 Amgen
11.5.1 Amgen Corporation Information
11.5.2 Amgen Overview
11.5.3 Amgen Bronchodilator Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Amgen Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Amgen Recent Developments
11.6 Kissei Pharmaceutical
11.6.1 Kissei Pharmaceutical Corporation Information
11.6.2 Kissei Pharmaceutical Overview
11.6.3 Kissei Pharmaceutical Bronchodilator Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Kissei Pharmaceutical Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Kissei Pharmaceutical Recent Developments
11.7 Mitsubishi Tanabe Pharma
11.7.1 Mitsubishi Tanabe Pharma Corporation Information
11.7.2 Mitsubishi Tanabe Pharma Overview
11.7.3 Mitsubishi Tanabe Pharma Bronchodilator Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Mitsubishi Tanabe Pharma Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mitsubishi Tanabe Pharma Recent Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Bronchodilator Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sanofi Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
11.9 Theron Pharmaceuticals
11.9.1 Theron Pharmaceuticals Corporation Information
11.9.2 Theron Pharmaceuticals Overview
11.9.3 Theron Pharmaceuticals Bronchodilator Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Theron Pharmaceuticals Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Theron Pharmaceuticals Recent Developments
11.10 Array BioPharma
11.10.1 Array BioPharma Corporation Information
11.10.2 Array BioPharma Overview
11.10.3 Array BioPharma Bronchodilator Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Array BioPharma Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Array BioPharma Recent Developments
11.11 Kyowa Hakko Kirin
11.11.1 Kyowa Hakko Kirin Corporation Information
11.11.2 Kyowa Hakko Kirin Overview
11.11.3 Kyowa Hakko Kirin Bronchodilator Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Kyowa Hakko Kirin Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Kyowa Hakko Kirin Recent Developments
11.12 Verona Pharma
11.12.1 Verona Pharma Corporation Information
11.12.2 Verona Pharma Overview
11.12.3 Verona Pharma Bronchodilator Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Verona Pharma Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Verona Pharma Recent Developments
11.13 Nycomed Pharma
11.13.1 Nycomed Pharma Corporation Information
11.13.2 Nycomed Pharma Overview
11.13.3 Nycomed Pharma Bronchodilator Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Nycomed Pharma Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Nycomed Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bronchodilator Industry Chain Analysis
12.2 Bronchodilator Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bronchodilator Production Mode & Process
12.4 Bronchodilator Sales and Marketing
12.4.1 Bronchodilator Sales Channels
12.4.2 Bronchodilator Distributors
12.5 Bronchodilator Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bronchodilator Industry Trends
13.2 Bronchodilator Market Drivers
13.3 Bronchodilator Market Challenges
13.4 Bronchodilator Market Restraints
14 Key Findings in The Global Bronchodilator Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Bronchodilator Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Short-acting Bronchodilator
Table 3. Major Manufacturers of Long-acting Bronchodilator
Table 4. Global Bronchodilator Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Bronchodilator Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Bronchodilator Sales by Region (2017-2022) & (K Doses)
Table 7. Global Bronchodilator Sales Market Share by Region (2017-2022)
Table 8. Global Bronchodilator Sales by Region (2023-2028) & (K Doses)
Table 9. Global Bronchodilator Sales Market Share by Region (2023-2028)
Table 10. Global Bronchodilator Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Bronchodilator Revenue Market Share by Region (2017-2022)
Table 12. Global Bronchodilator Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Bronchodilator Revenue Market Share by Region (2023-2028)
Table 14. Global Bronchodilator Sales by Manufacturers (2017-2022) & (K Doses)
Table 15. Global Bronchodilator Sales Share by Manufacturers (2017-2022)
Table 16. Global Bronchodilator Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Bronchodilator Revenue Share by Manufacturers (2017-2022)
Table 18. Bronchodilator Price by Manufacturers (2017-2022) &(USD/Dose)
Table 19. Global Bronchodilator Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Bronchodilator by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchodilator as of 2021)
Table 21. Bronchodilator Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Bronchodilator Product Offered
Table 23. Date of Manufacturers Enter into Bronchodilator Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bronchodilator Sales by Type (2017-2022) & (K Doses)
Table 26. Global Bronchodilator Sales by Type (2023-2028) & (K Doses)
Table 27. Global Bronchodilator Sales Share by Type (2017-2022)
Table 28. Global Bronchodilator Sales Share by Type (2023-2028)
Table 29. Global Bronchodilator Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Bronchodilator Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Bronchodilator Revenue Share by Type (2017-2022)
Table 32. Global Bronchodilator Revenue Share by Type (2023-2028)
Table 33. Bronchodilator Price by Type (2017-2022) & (USD/Dose)
Table 34. Global Bronchodilator Price Forecast by Type (2023-2028) & (USD/Dose)
Table 35. Global Bronchodilator Sales by Application (2017-2022) & (K Doses)
Table 36. Global Bronchodilator Sales by Application (2023-2028) & (K Doses)
Table 37. Global Bronchodilator Sales Share by Application (2017-2022)
Table 38. Global Bronchodilator Sales Share by Application (2023-2028)
Table 39. Global Bronchodilator Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Bronchodilator Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Bronchodilator Revenue Share by Application (2017-2022)
Table 42. Global Bronchodilator Revenue Share by Application (2023-2028)
Table 43. Bronchodilator Price by Application (2017-2022) & (USD/Dose)
Table 44. Global Bronchodilator Price Forecast by Application (2023-2028) & (USD/Dose)
Table 45. North America Bronchodilator Sales by Type (2017-2022) & (K Doses)
Table 46. North America Bronchodilator Sales by Type (2023-2028) & (K Doses)
Table 47. North America Bronchodilator Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Bronchodilator Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Bronchodilator Sales by Application (2017-2022) & (K Doses)
Table 50. North America Bronchodilator Sales by Application (2023-2028) & (K Doses)
Table 51. North America Bronchodilator Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Bronchodilator Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Bronchodilator Sales by Country (2017-2022) & (K Doses)
Table 54. North America Bronchodilator Sales by Country (2023-2028) & (K Doses)
Table 55. North America Bronchodilator Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Bronchodilator Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Bronchodilator Sales by Type (2017-2022) & (K Doses)
Table 58. Europe Bronchodilator Sales by Type (2023-2028) & (K Doses)
Table 59. Europe Bronchodilator Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Bronchodilator Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Bronchodilator Sales by Application (2017-2022) & (K Doses)
Table 62. Europe Bronchodilator Sales by Application (2023-2028) & (K Doses)
Table 63. Europe Bronchodilator Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Bronchodilator Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Bronchodilator Sales by Country (2017-2022) & (K Doses)
Table 66. Europe Bronchodilator Sales by Country (2023-2028) & (K Doses)
Table 67. Europe Bronchodilator Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Bronchodilator Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Bronchodilator Sales by Type (2017-2022) & (K Doses)
Table 70. Asia Pacific Bronchodilator Sales by Type (2023-2028) & (K Doses)
Table 71. Asia Pacific Bronchodilator Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Bronchodilator Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Bronchodilator Sales by Application (2017-2022) & (K Doses)
Table 74. Asia Pacific Bronchodilator Sales by Application (2023-2028) & (K Doses)
Table 75. Asia Pacific Bronchodilator Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Bronchodilator Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Bronchodilator Sales by Region (2017-2022) & (K Doses)
Table 78. Asia Pacific Bronchodilator Sales by Region (2023-2028) & (K Doses)
Table 79. Asia Pacific Bronchodilator Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Bronchodilator Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Bronchodilator Sales by Type (2017-2022) & (K Doses)
Table 82. Latin America Bronchodilator Sales by Type (2023-2028) & (K Doses)
Table 83. Latin America Bronchodilator Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Bronchodilator Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Bronchodilator Sales by Application (2017-2022) & (K Doses)
Table 86. Latin America Bronchodilator Sales by Application (2023-2028) & (K Doses)
Table 87. Latin America Bronchodilator Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Bronchodilator Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Bronchodilator Sales by Country (2017-2022) & (K Doses)
Table 90. Latin America Bronchodilator Sales by Country (2023-2028) & (K Doses)
Table 91. Latin America Bronchodilator Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Bronchodilator Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Bronchodilator Sales by Type (2017-2022) & (K Doses)
Table 94. Middle East and Africa Bronchodilator Sales by Type (2023-2028) & (K Doses)
Table 95. Middle East and Africa Bronchodilator Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Bronchodilator Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Bronchodilator Sales by Application (2017-2022) & (K Doses)
Table 98. Middle East and Africa Bronchodilator Sales by Application (2023-2028) & (K Doses)
Table 99. Middle East and Africa Bronchodilator Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Bronchodilator Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Bronchodilator Sales by Country (2017-2022) & (K Doses)
Table 102. Middle East and Africa Bronchodilator Sales by Country (2023-2028) & (K Doses)
Table 103. Middle East and Africa Bronchodilator Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Bronchodilator Revenue by Country (2023-2028) & (US$ Million)
Table 105. GlaxoSmithKline Corporation Information
Table 106. GlaxoSmithKline Description and Major Businesses
Table 107. GlaxoSmithKline Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 108. GlaxoSmithKline Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. GlaxoSmithKline Recent Developments
Table 110. Roche Corporation Information
Table 111. Roche Description and Major Businesses
Table 112. Roche Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 113. Roche Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Roche Recent Developments
Table 115. AstraZeneca Corporation Information
Table 116. AstraZeneca Description and Major Businesses
Table 117. AstraZeneca Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 118. AstraZeneca Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. AstraZeneca Recent Developments
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Major Businesses
Table 122. Boehringer Ingelheim Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 123. Boehringer Ingelheim Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Boehringer Ingelheim Recent Developments
Table 125. Amgen Corporation Information
Table 126. Amgen Description and Major Businesses
Table 127. Amgen Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 128. Amgen Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Amgen Recent Developments
Table 130. Kissei Pharmaceutical Corporation Information
Table 131. Kissei Pharmaceutical Description and Major Businesses
Table 132. Kissei Pharmaceutical Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 133. Kissei Pharmaceutical Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Kissei Pharmaceutical Recent Developments
Table 135. Mitsubishi Tanabe Pharma Corporation Information
Table 136. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 137. Mitsubishi Tanabe Pharma Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 138. Mitsubishi Tanabe Pharma Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Mitsubishi Tanabe Pharma Recent Developments
Table 140. Sanofi Corporation Information
Table 141. Sanofi Description and Major Businesses
Table 142. Sanofi Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 143. Sanofi Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Sanofi Recent Developments
Table 145. Theron Pharmaceuticals Corporation Information
Table 146. Theron Pharmaceuticals Description and Major Businesses
Table 147. Theron Pharmaceuticals Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 148. Theron Pharmaceuticals Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Theron Pharmaceuticals Recent Developments
Table 150. Array BioPharma Corporation Information
Table 151. Array BioPharma Description and Major Businesses
Table 152. Array BioPharma Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 153. Array BioPharma Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Array BioPharma Recent Developments
Table 155. Kyowa Hakko Kirin Corporation Information
Table 156. Kyowa Hakko Kirin Description and Major Businesses
Table 157. Kyowa Hakko Kirin Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 158. Kyowa Hakko Kirin Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Kyowa Hakko Kirin Recent Developments
Table 160. Verona Pharma Corporation Information
Table 161. Verona Pharma Description and Major Businesses
Table 162. Verona Pharma Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 163. Verona Pharma Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Verona Pharma Recent Developments
Table 165. Nycomed Pharma Corporation Information
Table 166. Nycomed Pharma Description and Major Businesses
Table 167. Nycomed Pharma Bronchodilator Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 168. Nycomed Pharma Bronchodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Nycomed Pharma Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Bronchodilator Distributors List
Table 173. Bronchodilator Customers List
Table 174. Bronchodilator Market Trends
Table 175. Bronchodilator Market Drivers
Table 176. Bronchodilator Market Challenges
Table 177. Bronchodilator Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Bronchodilator Product Picture
Figure 3. Global Bronchodilator Market Share by Type in 2021 & 2028
Figure 3. Short-acting Bronchodilator Product Picture
Figure 4. Long-acting Bronchodilator Product Picture
Figure 5. Global Bronchodilator Market Share by Application in 2021 & 2028
Figure 6. Asthma
Figure 7. Chronic Obstructive Pulmonary Disease
Figure 8. Others
Figure 9. Bronchodilator Report Years Considered
Figure 10. Global Bronchodilator Sales 2017-2028 (K Doses)
Figure 11. Global Bronchodilator Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Bronchodilator Revenue 2017-2028 (US$ Million)
Figure 13. Global Bronchodilator Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Bronchodilator Sales Market Share by Region (2017-2022)
Figure 15. Global Bronchodilator Sales Market Share by Region (2023-2028)
Figure 16. North America Bronchodilator Sales YoY (2017-2028) & (K Doses)
Figure 17. North America Bronchodilator Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Bronchodilator Sales YoY (2017-2028) & (K Doses)
Figure 19. Europe Bronchodilator Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Bronchodilator Sales YoY (2017-2028) & (K Doses)
Figure 21. Asia-Pacific Bronchodilator Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Bronchodilator Sales YoY (2017-2028) & (K Doses)
Figure 23. Latin America Bronchodilator Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Bronchodilator Sales YoY (2017-2028) & (K Doses)
Figure 25. Middle East & Africa Bronchodilator Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Bronchodilator Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Bronchodilator in the World: Market Share by Bronchodilator Revenue in 2021
Figure 28. Global Bronchodilator Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Bronchodilator Sales Market Share by Type (2017-2028)
Figure 30. Global Bronchodilator Revenue Market Share by Type (2017-2028)
Figure 31. Global Bronchodilator Sales Market Share by Application (2017-2028)
Figure 32. Global Bronchodilator Revenue Market Share by Application (2017-2028)
Figure 33. North America Bronchodilator Sales Market Share by Type (2017-2028)
Figure 34. North America Bronchodilator Revenue Market Share by Type (2017-2028)
Figure 35. North America Bronchodilator Sales Market Share by Application (2017-2028)
Figure 36. North America Bronchodilator Revenue Market Share by Application (2017-2028)
Figure 37. North America Bronchodilator Sales Share by Country (2017-2028)
Figure 38. North America Bronchodilator Revenue Share by Country (2017-2028)
Figure 39. U.S. Bronchodilator Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Bronchodilator Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Bronchodilator Sales Market Share by Type (2017-2028)
Figure 42. Europe Bronchodilator Revenue Market Share by Type (2017-2028)
Figure 43. Europe Bronchodilator Sales Market Share by Application (2017-2028)
Figure 44. Europe Bronchodilator Revenue Market Share by Application (2017-2028)
Figure 45. Europe Bronchodilator Sales Share by Country (2017-2028)
Figure 46. Europe Bronchodilator Revenue Share by Country (2017-2028)
Figure 47. Germany Bronchodilator Revenue (2017-2028) & (US$ Million)
Figure 48. France Bronchodilator Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Bronchodilator Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Bronchodilator Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Bronchodilator Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Bronchodilator Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Bronchodilator Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Bronchodilator Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Bronchodilator Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Bronchodilator Sales Share by Region (2017-2028)
Fig
  • Global Montelukast Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Montelukast Sodium market size was valued at US$ 336.3 million in 2023. With growing demand in downstream market, the Montelukast Sodium is forecast to a readjusted size of US$ 815.4 million by 2030 with a CAGR of 13.5% during review period. The research report highlights the growth potential of the global Montelukast Sodium market. Montelukast Sodium are expected to show stable growth in the future market. However, product d......
  • Global Montelukast Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132
    According to our (Global Info Research) latest study, the global Montelukast Sodium market size was valued at USD 353.8 million in 2023 and is forecast to a readjusted size of USD 803.8 million by 2030 with a CAGR of 12.4% during review period. Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chr......
  • Asthma Therapeutics - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 114
    The global Asthma Therapeutics market size is expected to reach US$ 27800 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Therapeutics in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Asthma Therapeutics market. Inhalation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......
  • Global Asthma Therapeutics Market Research Report 2023, Forecast to 2028
    Published: 15-Dec-2023        Price: US 2680 Onwards        Pages: 163
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Budesonide Aerosol Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 146
    Report Overview: The Global Budesonide Aerosol Market Size was estimated at USD 7996.70 million in 2022 and is projected to reach USD 41912.84 million by 2029, exhibiting a CAGR of 26.70% during the forecast period. This report provides a deep insight into the global Budesonide Aerosol market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key marke......
  • Global Asthma Therapeutics Professional Survey Report 2023, Forecast to 2028
    Published: 15-Dec-2023        Price: US 3280 Onwards        Pages: 139
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Montelukast Sodium Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 144
    Report Overview: Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis. The Global Montelukast Sodium Market Size was estimated at USD 816.70 million in 2022 and is projected to reach USD 1921.37 million by 20......
  • Global Doxofylline (API) Market Research Report 2023
    Published: 28-Nov-2023        Price: US 2900 Onwards        Pages: 88
    Doxofylline (also known as doxophylline) is a phosphodiesterase inhibiting bronchodilator used in The treatment of chronic respiratory diseases such as asthma and COPD. Like theophylline, it is a xanthine derivative. According to QYResearch's new survey, global Doxofylline (API) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with The CAGR of % during The period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Uk......
  • Global Montelukast Sodium Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 164
    Montelukast sodium is an organic sodium salt. Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked to rare cases of clinically apparent liver injury. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs